Table 2.
Trivalent Influenza Vaccines (TIV) licensed in the United States.
Vaccine | Manufacturer | Cell Substrate | Vaccine Dose | Vaccination Route | Indication |
---|---|---|---|---|---|
Fluzone HD | Sanofi | Egg | 60 mcg HA of each vaccine strain | Intramuscular | 65 years of age and above |
Fluvirin | Seqirus | Egg | 15 mcg HA of each vaccine strain | Intranasal | 4 years of age and above |
FLUAD | Seqirus | Egg | MF59C.1 adjuvanted; 15 mcg HA of each vaccine strain | Intramuscular | 65 years of age and above |
Afluria | Seqirus | Egg | 15 mcg HA of each vaccine strain | Intramuscular | 5 years of age and above |
Flublok (Discontinued) | Protein Sciences | Sf9 insect cells | 45 mcg HA of each vaccine strain | Intramuscular | 18 years of age and above |